Furthermore, our results suggest that the transcription factor Mta3 in the MoMFs subset may be a key factor in the ability of JQF to alleviate hepatic fibrosis in NAFLD. Here, MTA3 is linked to metabolic dysfunction-associated steatotic liver disease.